Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.74 |
| ▸ | CA1 | P00915 | 4/20 | 0.74 |
| ▸ | CA2 | P00918 | 4/20 | 0.74 |
| ▸ | CA7 | P43166 | 4/20 | 0.74 |
| ▸ | CA9 | Q16790 | 4/20 | 0.74 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.74 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.74 |
| ▸ | CA4 | P22748 | 3/20 | 0.74 |
| ▸ | CA6 | P23280 | 3/20 | 0.74 |
| ▸ | LMNA | P02545 | 3/20 | 0.74 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.74 |
| ▸ | MAPT | P10636 | 3/20 | 0.74 |
| ▸ | FUT7 | Q11130 | 2/20 | 0.74 |
| ▸ | CA3 | P07451 | 2/20 | 0.74 |
| ▸ | CA5A | P35218 | 2/20 | 0.74 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.74 |
| ▸ | TP53 | P04637 | 1/20 | 0.74 |
| ▸ | SELL | P14151 | 1/20 | 0.74 |
| ▸ | HPGD | P15428 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gallic Acid SCHEMBL29503723 | 0.87 | CA12 (0.74) | CA12CA1CA2CA7CA9 | |
| Gallic Acid SCHEMBL28021798 | 0.87 | CA12 (0.74) | CA12CA1CA2CA7CA9 | |
| Gallic Acid SCHEMBL5421738 | 0.86 | CA12 (0.90) | CA12CA1CA2CA7CA9 | |
| Gallic Acid SCHEMBL2726519 | 0.86 | CA12 (0.90) | CA12CA1CA2CA7CA9 | |
| Gallic Acid SCHEMBL27648549 | 0.86 | CA12 (0.90) | CA12CA1CA2CA7CA9 | |
| Gallic Acid SCHEMBL28279123 | 0.86 | CA12 (0.90) | CA12CA1CA2CA7CA9 | |
| Gallic Acid SCHEMBL15012 | 0.86 | CA12 (1.00) | CA12CA1CA2CA7CA9 | |
| Gallic Acid SCHEMBL30375631 | 0.86 | CA12 (1.00) | CA12CA1CA2CA7CA9 | |
| Gallic Acid SCHEMBL4918056 | 0.86 | CA12 (1.00) | CA12CA1CA2CA7CA9 | |
| Gallic Acid SCHEMBL678990 | 0.86 | CA12 (1.00) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210251947-A1 | STABLE FORMULATIONS OF DRONABINOL | TRYAGx Labs Inc. | 2021-08-19 | — | — | US | claimed |
| WO-2021163023-A1 | STABLE FORMULATIONS OF DRONABINOL | TRYAGx Labs Inc. (US) | 2021-08-19 | — | — | WO | claimed |
| CN-117447837-A | Bio-based polyamide composition and preparation method thereof, bearing retainer and preparation method thereof | 苏州汇川联合动力系统股份有限公司 | 2024-01-26 | — | — | CN | disclosed |
| CN-115698169-A | Ethylene-vinyl alcohol copolymer resin composition, multilayer structure, and package | 三菱化学株式会社 | 2023-02-03 | — | — | CN | disclosed |
| US-20210251947-A1 | STABLE FORMULATIONS OF DRONABINOL | TRYAGx Labs Inc. | 2021-08-19 | — | — | US | disclosed |
| WO-2021163023-A1 | STABLE FORMULATIONS OF DRONABINOL | TRYAGx Labs Inc. (US) | 2021-08-19 | — | — | WO | disclosed |
| US-20090047336-A1 | NOVEL FORMULATION OF DEHYDRATED LIPID VESICLES FOR CONTROLLED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT VIA INHALATION | HONG KONG BAPTIST UNIVERSITY (CN) | 2009-02-19 | — | — | US | disclosed |
| EP-0343806-A2 | Stabilised fat compositions | UNIROYAL CHEMICAL COMPANY, Inc. (US) | 1989-11-29 | — | — | EP | disclosed |
| US-4839188-A | TRIS(N-ALKYL-P-PHENYLENE DIAMINO)-1,3,5-TRIAZINES | UNIROYAL CHEMICAL COMPANY, INC. (US) | 1989-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210251947-A1 | STABLE FORMULATIONS OF DRONABINOL | CNR2, CNR1, GPR18 | CA12 1894/4885CA1 2798/4885CA2 2209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.